Known internationally for their A-list client portfolio and award-winning media campaigns, J Public Relations (JPR) is expanding its well-being portfolio with the representation of Genalyte. The company’s rapid serology testing, backed by real-time diagnostics and analytics, has placed it at the forefront of COVID-19 antibody testing, paving the way forward in the fight against the novel coronavirus (SARS-CoV-2).
The state of the current global environment has encouraged companies to think more strategically about their skillset and how best to expand services in a thoughtful and strategic manner. As JPR continues to broaden its portfolio, Genalyte is an innovative company with an impactful tool to help find a solution to one of the biggest challenges in the world today. The company and its leadership have also taken on the responsibility of educating consumers about the important role of serology testing, in combination with diagnostic testing, to better understand COVID-19. The company’s rapid SARS-CoV-2 Multi-Antigen Serology Panel on its U.S. Food and Drug Administration (FDA)-cleared MaverickTMDiagnostic System tests for the detection of IgG and IgM antibodies that the body produces in response to the coronavirus.
“We’re proud to welcome such an innovative brand like Genalyte to our JPR family. To be able to tell such powerful stories during this time is extremely important to us and through our work with Genalyte, we’re able to deliver vital information to the community,” says Founding Partner Jamie Lynn O’Grady.
Genalyte’s Maverick instrument allows the company to deliver central lab-quality results in 20 minutes at decentralized testing locations. The high-quality, rapid testing provides immediate feedback to worried patients and helps employers make effective return-to-work decisions. The antibody test represents a crucial step in helping to develop an understanding of the virus, including how long antibodies stay in the body and if those with antibodies are less susceptible to reinfection.
The impacts of COVID-19 have paved the way for JPR to broaden its portfolio, building upon their first-class media relationships to strengthen brand awareness and bring important messages directly to a target consumer audience.
